IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 66 filers reported holding IMMUNE DESIGN CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,037,000 | +785.2% | 1,031,905 | +96.6% | 0.01% | +400.0% |
| Q4 2018 | $682,000 | +34.3% | 524,805 | +256.5% | 0.00% | 0.0% |
| Q3 2018 | $508,000 | -60.3% | 147,214 | +19.1% | 0.00% | -50.0% |
| Q3 2017 | $1,279,000 | -6.2% | 123,591 | -11.6% | 0.00% | 0.0% |
| Q2 2017 | $1,363,000 | +79.3% | 139,800 | +25.1% | 0.00% | +100.0% |
| Q1 2017 | $760,000 | +233.3% | 111,740 | +170.0% | 0.00% | – |
| Q4 2016 | $228,000 | -74.2% | 41,389 | -64.5% | 0.00% | -100.0% |
| Q3 2016 | $883,000 | – | 116,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|